Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
JCM | Free Full-Text | Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
Disease Free Survival - an overview | ScienceDirect Topics
Kaplan-Meier survival analysis
Progression-Free-Survival (PFS) Analysis in Solid Tumor Clinical Studies
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints - The Cancer Letter
Definition of Composite Progression-Free Survival End Point | Download Table
Measures of Cancer Survival
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis | The BMJ
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr Oncol
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
